The Polymorphisms of the Peroxisome-Proliferator Activated Receptors' Alfa Gene Modify the Aerobic Training Induced Changes of Cholesterol and Glucose

被引:17
作者
Maciejewska-Skrendo, Agnieszka [1 ]
Buryta, Maciej [1 ]
Czarny, Wojciech [2 ]
Krol, Pawel [2 ]
Spieszny, Michal [3 ]
Stastny, Petr [4 ]
Petr, Miroslav [4 ]
Safranow, Krzysztof [5 ]
Sawczuk, Marek [6 ]
机构
[1] Gdansk Univ Phys Educ & Sport, Dept Mol Biol, Fac Phys Educ, PL-80336 Gdansk, Poland
[2] Univ Rzeszow, Dept Anat & Anthropol, Fac Phys Educ, PL-35310 Rzeszow, Poland
[3] Univ Phys Educ & Sport, Inst Sports, Fac Phys Educ, PL-31571 Krakow, Poland
[4] Charles Univ Prague, Dept Sport Games, Faulty Phys Educ & Sport, Prague 16252, Czech Republic
[5] Pomeranian Med Univ, Dept Biochem & Med Chem, PL-70204 Szczecin, Poland
[6] Gdansk Univ Phys Educ & Sport, Unit Phys Med, Fac Tourism & Recreat, PL-80336 Gdansk, Poland
关键词
human performance; aerobic training; genetic predisposition; lipid metabolism; glucose tolerance; VO(2)max; mitochondria activity; cholesterol levels; SINGLE NUCLEOTIDE POLYMORPHISMS; FATTY-ACIDS; FUNCTIONAL-CHARACTERIZATION; TISSUE DISTRIBUTION; LDL SIZE; ASSOCIATION; EXPRESSION; IDENTIFICATION; FENOFIBRATE; METABOLISM;
D O I
10.3390/jcm8071043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: PPAR alpha is a transcriptional factor that controls the expression of genes involved in fatty acid metabolism, including fatty acid transport, uptake by the cells, intracellular binding, and activation, as well as catabolism (particularly mitochondrial fatty acid oxidation) or storage. PPARA gene polymorphisms may be crucial for maintaining lipid homeostasis and in this way, being responsible for developing specific training-induced physiological reactions. Therefore, we have decided to check if post-training changes of body mass measurements as well as chosen biochemical parameters are modulation by the PPARA genotypes. Methods: We have examined the genotype and alleles' frequencies (described in PPARA rs1800206 and rs4253778 polymorphic sites) in 168 female participants engaged in a 12-week training program. Body composition and biochemical parameters were measured before and after the completion of a whole training program. Results: Statistical analyses revealed that PPARA intron 7 rs4253778 CC genotype modulate training response by increasing low-density lipoproteins (LDL) and glucose concentration, while PPARA Leu162Val rs1800206 CG genotype polymorphism interacts in a decrease in high-density lipoproteins (HDL) concentration. Conclusions: Carriers of PPARA intron 7 rs4253778 CC genotype and Leu162Val rs1800206 CG genotype might have potential negative training-induced cholesterol and glucose changes after aerobic exercise.
引用
收藏
页数:15
相关论文
共 59 条
[1]   EFFECTS OF AEROBIC AND ANAEROBIC TRAINING ON PLASMA-LIPOPROTEINS [J].
AELLEN, R ;
HOLLMANN, W ;
BOUTELLIER, U .
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 1993, 14 (07) :396-400
[2]   PPARα gene variation and physical performance in Russian athletes [J].
Ahmetov, II ;
Mozhayskaya, IA ;
Flavell, DM ;
Astratenkova, IV ;
Komkova, AI ;
Lyubaeva, EV ;
Tarakin, PP ;
Shenkman, BS ;
Vdovina, AB ;
Netreba, AI ;
Popov, DV ;
Vinogradova, OL ;
Montgomery, HE ;
Rogozkin, VA .
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2006, 97 (01) :103-108
[3]   CONTRIBUTION OF OXIDATIVE-METABOLISM AND GLYCOLYSIS TO ATP PRODUCTION IN HYPERTROPHIED HEARTS [J].
ALLARD, MF ;
SCHONEKESS, BO ;
HENNING, SL ;
ENGLISH, DR ;
LOPASCHUK, GD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (02) :H742-H750
[4]   PPARγ2 Gene Pro12Ala and PPARα Gene Leu162Val Single Nucleotide Polymorphisms Interact with Dietary Intake of Fat in Determination of Plasma Lipid Concentrations [J].
AlSaleh, Aseel ;
Frost, Gary S. ;
Griffin, Bruce A. ;
Lovegrove, Julie A. ;
Jebb, Susan A. ;
Sanders, Thomas A. B. ;
O'Dell, Sandra D. .
JOURNAL OF NUTRIGENETICS AND NUTRIGENOMICS, 2011, 4 (06) :354-366
[5]   Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-α gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes -: The STOP-NIDDM trial [J].
Andrulionyte, Laura ;
Kuulasmaa, Teemu ;
Chiasson, Jean-Louis ;
Laakso, Markku .
DIABETES, 2007, 56 (04) :1181-1186
[6]   Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients [J].
Auboeuf, D ;
Rieusset, J ;
Fajas, L ;
Vallier, P ;
Frering, V ;
Riou, JP ;
Staels, P ;
Auwerx, J ;
Laville, M ;
Vidal, H .
DIABETES, 1997, 46 (08) :1319-1327
[7]   Deactivation of peroxisome proliferator-activated receptor-α during cardiac hypertrophic growth [J].
Barger, PM ;
Brandt, JM ;
Leone, TC ;
Weinheimer, CJ ;
Kelly, DP .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (12) :1723-1730
[8]  
Berneis K, 2004, SWISS MED WKLY, V134, P720
[9]   Metabolic origins and clinical significance of LDL heterogeneity [J].
Berneis, KK ;
Krauss, RM .
JOURNAL OF LIPID RESEARCH, 2002, 43 (09) :1363-1379
[10]   Effects of Peroxisome Proliferator-Activated Receptors, Dietary Fat Intakes and Gene-Diet Interactions on Peak Particle Diameters of Low-Density Lipoproteins [J].
Bouchard-Mercier, Annie ;
Godin, Gaston ;
Lamarche, Benoit ;
Perusse, Louis ;
Vohl, Marie-Claude .
JOURNAL OF NUTRIGENETICS AND NUTRIGENOMICS, 2011, 4 (01) :36-48